Table 1.
Non-HAND (n=84) | HAND (n=50) | p value | |
---|---|---|---|
Age, years, mean (SD) | 38.65(9.46) | 36.77(7.91) | NS |
Male, n (%) | 65(77.38) | 11(22) | <0.001 |
Education, years, mean (SD) | 5.23(1.46) | 4.85(1.24) | NS |
Race/ethnicity — minority, n (%) | 6(7.14) | 3(6) | NS |
Estimated infective time, years, mean (SD) | 4.63(2.68) | 5.16(3.24) | NS |
ART treatment time, months, mean (SD) | 13.26(3.25) | 12.03(4.78) | NS |
HIV infection risks | |||
MSM, n (%) | 14(16.67) | 8(16) | NS |
IDU, n (%) | 8(9.52) | 3(6) | NS |
Heterosexual, n (%) | 27(32.14) | 17(34) | NS |
FPD, n (%) | 32(38.1) | 20(40) | NS |
Others, n (%) | 3(3.57) | 2(4) | NS |
HAND HIV-associated neurocognitive disorders, ART antiretroviral therapy, MSM men who have sex with men, IDU injecting drug user, FPD former plasma donors, NS non-significant at p<0.05